Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
Why this paper is included
Supporting source evidence:
Average adjusted food group and micronutrient intake for survivors of cancer post-neurotoxic chemotherapy with ranging severity of chemotherapy-induced peripheral neuropathy (CIPN) adjusting for caloric intake, age, race, sex, BMI, and food security per 1000 kilocalories Dietary component(N = 136) | CIPN severitya | Omnibus differences, p-value | OR(95% CI)b | ORp-value | Average amount of intake by CIPN severity level | 0 | 1 | 2 | 3 | Odds of a greater CIPN severity | None(n = 60) | Mild(n = 30) | Moderate (n = 35) | Severe (n = 11): Vitamin D (IU/day) | 135.68(111.55, 159.82) | 120.82(92.61, 149.04) | 123.66(95.44, 151.88) | 125.35(74.52, 176.18) | 0.88 | 1.00(0.99, 1.00) | 0.28
Source: Results table. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Secondary analysis.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Meta-analysis unclear · Blinding unclear / not reported · Human research reported
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
The data for this secondary analysis were from a cross-sectional study that aimed to determine the association between diet quality, macronutrients, and CIPN among post-treatment cancer survivors [].
Source: Methods.
Participants were categorized as experiencing CIPN (≥ 1/4) or not experiencing CIPN (score = 0) based on the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE™) numbness and tingling severity item, which measures the severity of CIPN-related pain.
Source: Methods.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Food groups and micronutrients associated with chemotherapy-induced peripheral neuropathy in survivors of cancer post-neurotoxic treatment
Secondary analysis · Supportive Care in Cancer · 2025
Original publication title
Food groups and micronutrients associated with chemotherapy-induced peripheral neuropathy in survivors of cancer post-neurotoxic treatment
© The Author(s) 2025
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
Abstract: What objectives does the paper state?
Determine the association of food group and micronutrient intake with chemotherapy-induced peripheral neuropathy (CIPN) among survivors of cancer.
Source: PurposeAbstract: What methods does the paper describe?
In this cross-sectional study, participants completed the PRO-CTACE™ numbness and tingling severity item and VioScreen™ Research Food Frequency Questionnaire to determine CIPN status and dietary intake, respectively. Separate covariate-adjusted linear, logistic, and ordered logistic regression models were used to calculate the mean food group and micronutrient amounts and the associations with CIPN status and severity. As a secondary analysis of prior research that was not powered to detect these associations, we considered p ≤ 0.10 as an indicator of relevance for future study.
Source: MethodsAbstract: Results
A total of 136 participants completed the surveys and questionnaires. Participants with greater daily intake of refined grains (OR = 2.05; 95% CI, 1.22, 3.46) and less intake of tomatoes (OR = 0.10; 95% CI, 0.10, 1.14), fish (OR = 0.21; 95% CI, 0.06, 0.75), eggs (OR = 0.06; 95% CI, 0.01, 0.34), and selenium (OR = 0.96; 95% CI, 0.92, 1.00) were associated with increased odds of having CIPN. The odds of experiencing worse CIPN severity increased with each additional serving of refined grains (OR = 1.66; 95% CI, 1.11, 2.48) and decreased with each extra serving of poultry (OR = 0.58; 95% CI, 0.31, 1.08), fish (OR = 0.18; 95% CI, 0.05, 0.61), egg (OR = 0.08; 95% CI, 0.02, 0.39), legumes (OR = 0.04; 95% CI, 0.00, 1.49), and selenium (OR = 0.96; 95% CI, 0.93, 1.35).
Source: ResultsAbstract: Conclusion
There are meaningful intake differences between participants with and without CIPN. Further research is needed to establish a dietary intervention using the findings in a larger population.
Source: ConclusionAuthors’ abstract
Purpose
Determine the association of food group and micronutrient intake with chemotherapy-induced peripheral neuropathy (CIPN) among survivors of cancer.
Methods
In this cross-sectional study, participants completed the PRO-CTACE™ numbness and tingling severity item and VioScreen™ Research Food Frequency Questionnaire to determine CIPN status and dietary intake, respectively. Separate covariate-adjusted linear, logistic, and ordered logistic regression models were used to calculate the mean food group and micronutrient amounts and the associations with CIPN status and severity. As a secondary analysis of prior research that was not powered to detect these associations, we considered p ≤ 0.10 as an indicator of relevance for future study.
Results
A total of 136 participants completed the surveys and questionnaires. Participants with greater daily intake of refined grains (OR = 2.05; 95% CI, 1.22, 3.46) and less intake of tomatoes (OR = 0.10; 95% CI, 0.10, 1.14), fish (OR = 0.21; 95% CI, 0.06, 0.75), eggs (OR = 0.06; 95% CI, 0.01, 0.34), and selenium (OR = 0.96; 95% CI, 0.92, 1.00) were associated with increased odds of having CIPN. The odds of experiencing worse CIPN severity increased with each additional serving of refined grains (OR = 1.66; 95% CI, 1.11, 2.48) and decreased with each extra serving of poultry (OR = 0.58; 95% CI, 0.31, 1.08), fish (OR = 0.18; 95% CI, 0.05, 0.61), egg (OR = 0.08; 95% CI, 0.02, 0.39), legumes (OR = 0.04; 95% CI, 0.00, 1.49), and selenium (OR = 0.96; 95% CI, 0.93, 1.35).
Conclusion
There are meaningful intake differences between participants with and without CIPN. Further research is needed to establish a dietary intervention using the findings in a larger population.
Publication and source details
Original title: Food groups and micronutrients associated with chemotherapy-induced peripheral neuropathy in survivors of cancer post-neurotoxic treatment
Karly Miller; Suzanna Zick; Robert Ploutz-Snyder; Edward A. Ruiz-Narváez; Robert Knoerl
Supportive Care in Cancer · 2025
© The Author(s) 20252025https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.https://doi.org/10.13039/100019216Academy of Nutrition and Dieteticshttps://doi.org/10.13039/100006801Horace H. Rackham School of Graduate Studies, University of Michiganhttps://doi.org/10.13039/100000054National Cancer InstituteP30CA046592Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-11T03:16:43.266438+00:00
DOI: 10.1007/s00520-025-09827-6 · PMC12373525